BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kadam SB, Sukhramani GS, Bishnoi P, Pable AA, Barvkar VT. SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights. J Basic Microbiol 2021;61:180-202. [PMID: 33460172 DOI: 10.1002/jobm.202000537] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Zhang L, Chen S, Ji W, Li C, Ren L. Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic. Infect Genet Evol 2021;93:104971. [PMID: 34146731 DOI: 10.1016/j.meegid.2021.104971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wielgat P, Narejko K, Car H. SARS-CoV-2 Attacks in the Brain: Focus on the Sialome. Cells 2022;11:1458. [DOI: 10.3390/cells11091458] [Reference Citation Analysis]
3 Goraichuk IV, Arefiev V, Stegniy BT, Gerilovych AP. Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2. Virus Res 2021;302:198473. [PMID: 34118360 DOI: 10.1016/j.virusres.2021.198473] [Reference Citation Analysis]
4 Emrani J, Ahmed M, Jeffers-Francis L, Teleha JC, Mowa N, Newman RH, Thomas MD. SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A review. Int J Biol Macromol 2021;193:1249-73. [PMID: 34756970 DOI: 10.1016/j.ijbiomac.2021.10.172] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Al-Ardhi FM, Novotny L, Alhunayan A, Al-Tannak NF. Comparison of remdesivir and favipiravir - the anti-Covid-19 agents mimicking purine RNA constituents. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021. [PMID: 34782799 DOI: 10.5507/bp.2021.063] [Reference Citation Analysis]
6 Colson A, Depoix CL, Dessilly G, Baldin P, Danhaive O, Hubinont C, Sonveaux P, Debiève F. Clinical and in Vitro Evidence against Placenta Infection at Term by Severe Acute Respiratory Syndrome Coronavirus 2. Am J Pathol 2021;191:1610-23. [PMID: 34111431 DOI: 10.1016/j.ajpath.2021.05.009] [Reference Citation Analysis]
7 Ahmad W, Shabbiri K. Two years of SARS-CoV-2 infection (2019-2021): structural biology, vaccination, and current global situation. Egypt J Intern Med 2022;34:5. [PMID: 35043040 DOI: 10.1186/s43162-021-00092-7] [Reference Citation Analysis]
8 Chapoval SP, Keegan AD. Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection. Mol Med 2021;27:162. [PMID: 34961486 DOI: 10.1186/s10020-021-00423-y] [Reference Citation Analysis]
9 Ghafoor R, Ali SM, Patil A, Goldust M. Association of androgenetic alopecia and severity of coronavirus disease 2019. J Cosmet Dermatol 2021. [PMID: 34918457 DOI: 10.1111/jocd.14683] [Reference Citation Analysis]
10 Tay DJW, Lew ZZR, Chu JJH, Tan KS. Uncovering Novel Viral Innate Immune Evasion Strategies: What Has SARS-CoV-2 Taught Us? Front Microbiol 2022;13:844447. [DOI: 10.3389/fmicb.2022.844447] [Reference Citation Analysis]
11 Tsverava L, Chitadze N, Chanturia G, Kekelidze M, Dzneladze D, Imnadze P, Gamkrelidze A, Lagani V, Khuchua Z, Solomonia R; Institute of Chemical Biology, Ilia State University, Tbilisi, Georgia, I.Beritashvili Center of Experimental Biomedicine, Tbilisi, Georgia, National Center for Disease Control, Tbilisi, Georgia, Sechenov University, Department of Biochemistry, Moscow, Russia, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology KAUST, Thuwal, Saudi Arabia. . ALLERGY 2022;6:6-13. [DOI: 10.3934/allergy.2022002] [Reference Citation Analysis]
12 Kadam SB, Sukhramani GS, Bishnoi P, Pable AA, Barvkar VT. SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights. J Basic Microbiol 2021;61:180-202. [PMID: 33460172 DOI: 10.1002/jobm.202000537] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
13 Yang H, Liu P, Zhang Y, Du T, Zhou Y, Lu S, Peng X. Characteristic analysis of Omicron‐included SARS‐CoV‐2 variants of concern. MedComm 2022;3. [DOI: 10.1002/mco2.129] [Reference Citation Analysis]
14 Tatsi EB, Filippatos F, Michos A. SARS-CoV-2 variants and effectiveness of vaccines: a review of current evidence. Epidemiol Infect 2021;149:e237. [PMID: 34732275 DOI: 10.1017/S0950268821002430] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
15 Wu J, Liu X, Shao J, Zhang Y, Lu R, Xue H, Xu Y, Wang L, Zhou H, Yu L, Yue M, Dong C. Expression of plasma IFN signaling-related miRNAs during acute SARS-CoV-2 infection and its association with RBD-IgG antibody response. Virol J 2021;18:244. [PMID: 34876159 DOI: 10.1186/s12985-021-01717-7] [Reference Citation Analysis]
16 Yu J, Sun S, Tang Q, Wang C, Yu L, Ren L, Li J, Zhang Z. Establishing reference sequences for each clade of SARS-CoV-2 to provide a basis for virus variation and function research. J Med Virol 2021. [PMID: 34821382 DOI: 10.1002/jmv.27476] [Reference Citation Analysis]